» Articles » PMID: 8795584

Inflammatory Infiltrate in Invasive Lobular and Ductal Carcinoma of the Breast

Overview
Journal Br J Cancer
Specialty Oncology
Date 1996 Sep 1
PMID 8795584
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

The significance of inflammation in carcinoma of the breast is controversial. Little attention has been paid to different patterns of inflammation or inflammation associated with different histological types of carcinoma. We have looked at the pattern of inflammation in 123 invasive mammary carcinomas (including 46 lobular), and characterised the inflammatory cells with immunohistochemistry in 21. We found different patterns of inflammation in ductal and lobular carcinoma. Diffuse inflammation was seen more in ductal carcinoma, particularly of high grade, and was predominantly composed of macrophages and T cells. It was associated with necrosis, but the correlation was weak, suggesting that other factors are important. Perilobular inflammation was seen most frequently in lobular and high-grade ductal carcinomas, particularly at the tumour edge. Perivascular inflammation was also largely at the tumour edge, but was not more common in any tumour type. In contrast to the diffuse inflammation, the perivascular and perilobular inflammation was composed of T and B cells. Normal lobules at the tumour edge showed consistent expression of HLA-DR, whereas lobules away from the tumour were negative. A combination of perilobular and perivascular inflammation composed of B and T cells with epithelial expression of HLA-DR mimicking lymphocytic lobulitis was seen more frequently in lobular than ductal carcinoma.

Citing Articles

PD-L1 Expression and Tumor-infiltrating Lymphocytes in Breast Cancer: Clinicopathological Analysis in Women Younger than 40 Years Old.

Evangelou Z, Papoudou-Bai A, Karpathiou G, Kourea H, Kamina S, Goussia A In Vivo. 2020; 34(2):639-647.

PMID: 32111764 PMC: 7157900. DOI: 10.21873/invivo.11818.


Prediction of Bone Metastasis in Inflammatory Breast Cancer Using a Markov Chain Model.

Fujii T, Mason J, Chen A, Kuhn P, Woodward W, Tripathy D Oncologist. 2019; 24(10):1322-1330.

PMID: 30952823 PMC: 6795167. DOI: 10.1634/theoncologist.2018-0713.


Eicosapentaenoic acid in combination with EPHA2 inhibition shows efficacy in preclinical models of triple-negative breast cancer by disrupting cellular cholesterol efflux.

Torres-Adorno A, Vitrac H, Qi Y, Tan L, Levental K, Fan Y Oncogene. 2018; 38(12):2135-2150.

PMID: 30459358 PMC: 6430703. DOI: 10.1038/s41388-018-0569-5.


Prognostic Evaluation of Epidermal Growth Factor Receptor (EGFR) Genotype and Phenotype Parameters in Triple-negative Breast Cancers.

Levva S, Kotoula V, Kostopoulos I, Manousou K, Papadimitriou C, Papadopoulou K Cancer Genomics Proteomics. 2017; 14(3):181-195.

PMID: 28446533 PMC: 5420819. DOI: 10.21873/cgp.20030.


In-silico insights on the prognostic potential of immune cell infiltration patterns in the breast lobular epithelium.

Alfonso J, Schaadt N, Schonmeyer R, Brieu N, Forestier G, Wemmert C Sci Rep. 2016; 6:33322.

PMID: 27659691 PMC: 5034260. DOI: 10.1038/srep33322.


References
1.
Lampejo O, Barnes D, Smith P, Millis R . Evaluation of infiltrating ductal carcinomas with a DCIS component: correlation of the histologic type of the in situ component with grade of the infiltrating component. Semin Diagn Pathol. 1994; 11(3):215-22. View

2.
Scholl S, Pallud C, Beuvon F, Hacene K, Stanley E, Rohrschneider L . Anti-colony-stimulating factor-1 antibody staining in primary breast adenocarcinomas correlates with marked inflammatory cell infiltrates and prognosis. J Natl Cancer Inst. 1994; 86(2):120-6. DOI: 10.1093/jnci/86.2.120. View

3.
Lee A, Millis R, Bobrow L . Lymphocytic lobulitis and carcinoma of the breast. Histopathology. 1996; 28(1):94-5. View

4.
Black M, SPEER F . Periductal lymphoid infiltrations in mammary tissue. AMA Arch Pathol. 1955; 60(4):457-61. View

5.
Alderson M, Hamlin I, Staunton M . The relative significance of prognostic factors in breast carcinoma. Br J Cancer. 1971; 25(4):646-56. PMC: 2008856. DOI: 10.1038/bjc.1971.80. View